trending Market Intelligence /marketintelligence/en/news-insights/trending/udh0b8fynn7yyy1e5hwffa2 content esgSubNav
In This List

ContraVir stockholders approve reverse stock split

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


ContraVir stockholders approve reverse stock split

ContraVir Pharmaceuticals Inc.'s stockholders approved a reverse stock split of the company's issued and outstanding common stock at a March 9 annual meeting.

The split ratio will be determined by the board within a range of 1-for-5 and 1-for-20 and is expected to be implemented on or before Feb. 21, 2019.